Synthase Biotech develops and manufactures high-quality enzyme technologies aimed at extending human lifespan through enhanced metabolic processes. Their products address the decline in enzyme activity associated with aging, promoting better health and longevity.
Funding
$8.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Enzyme activity declines with age, leading to less efficient metabolic processes. This can result in a variety of health issues and a reduced lifespan.
Solution
Synthase Biotech develops and manufactures enzyme technologies designed to enhance metabolic processes and extend human lifespan. Their products aim to counteract the age-related decline in enzyme activity, thereby promoting improved health and longevity. By addressing this fundamental aspect of aging, Synthase Biotech seeks to provide solutions that support overall well-being and potentially increase lifespan.
Target Audience
The primary target audience includes individuals interested in longevity, health optimization, and mitigating the effects of aging, as well as researchers and healthcare professionals in the field of anti-aging and metabolic health.
Features
- Enzyme technologies to enhance metabolic processes
- Products designed to counteract age-related decline in enzyme activity